Viewing Study NCT03227861


Ignite Creation Date: 2025-12-24 @ 11:45 AM
Ignite Modification Date: 2025-12-27 @ 6:34 AM
Study NCT ID: NCT03227861
Status: COMPLETED
Last Update Posted: 2025-02-04
First Post: 2017-07-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care
Sponsor: Janssen Scientific Affairs, LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-07-31
Start Date Type: ACTUAL
Primary Completion Date: 2019-01-03
Primary Completion Date Type: ACTUAL
Completion Date: 2019-09-04
Completion Date Type: ACTUAL
First Submit Date: 2017-07-21
First Submit QC Date: None
Study First Post Date: 2017-07-24
Study First Post Date Type: ACTUAL
Results First Submit Date: 2019-12-19
Results First Submit QC Date: None
Results First Post Date: 2020-01-07
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-01-31
Last Update Post Date: 2025-02-04
Last Update Post Date Type: ACTUAL